Joan Forns

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Peritoneal Dialysis

Cognitive Impairment

Top Venues

Neurology and therapy

American journal of epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Jaume Aguado, Lia Gutiérrez, Joan Forns, Julia Vila-Guilera, Kenneth J Rothman, Xabier Garcia de Albeniz
Effect of Different Durations of Treatment With Antihypertensive Drugs With Anticholinergic Effects on the Risk of Dementia: A Target Trial Emulation Study. American journal of epidemiology (2024)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
Joan Forns, Elena Dudukina, David Hägg, Péter Szentkúti, Karin Gembert, Estel Plana, Alicia W Gilsenan, Erzsébet Horváth-Puhó, Vera Ehrenstein, Johan Reutfors, Cristina Rebordosa
Risk of Major Cardiovascular and Cerebrovascular Events in Users of Lisdexamfetamine and Other Medications for Attention-Deficit/Hyperactivity Disorder in Denmark and Sweden: A Population-Based Cohort Study. Neurology and therapy 11 (4) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety (2022)
J Bradley Layton, Joan Forns, Lisa J McQuay, Heather E Danysh, Colleen Dempsey, Mary S Anthony, Mary Ellen Turner
Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety 46 (2) (2022)
J Bradley Layton, Joan Forns, Mary Ellen Turner, Colleen Dempsey, Jennifer L Bartsch, Mary S Anthony, Heather E Danysh, Mary E Ritchey, George Demos
Falls and Fractures in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study. Drugs - real world outcomes (2021)
Joan Forns, J Bradley Layton, Jennifer Bartsch, Mary Ellen Turner, Colleen Dempsey, Mary Anthony, Mary E Ritchey, George Demos
Increased risk of falls and fractures in patients with psychosis and Parkinson disease. PloS one 16 (1) (2021)
Joan Forns, Miguel Cainzos-Achirica, Maja Hellfritzsch, Rosa Morros, Beatriz Poblador-Plou, Nina Sahlertz Kristiansen, Maria Giner-Soriano, Alexandra Prados-Torres, Jesper Hallas, Jordi Cortés, Jordi Castellsagué, Emmanuelle Jacquot, Nicolas Deltour, Susana Perez-Gutthann, Manel Pladevall
Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources. Pharmacoepidemiology and drug safety 28 (7) (2019)